Feb 18, 2026 06:19AM
Jan 16, 2026 12:01PM
Nov 20, 2025 08:30AM
Nov 17, 2025 08:30AM
Nov 10, 2025 09:31AM
Oct 27, 2025 06:33AM
Sep 30, 2025 05:23PM Novartis wins FDA approval for oral chronic urticaria treatment
Sep 30, 2025 05:23PM
Sep 30, 2025 04:16PM
Aug 11, 2025 01:20AM
Jul 31, 2025 04:30PM
Jul 31, 2025 04:30PM
Jun 11, 2025 08:30AM
Apr 9, 2025 05:00AM Barbara Weber, M.D., Elected to ITM Supervisory Board
Mar 27, 2025 08:30AM
Mar 20, 2025 07:40PM
Mar 20, 2025 07:37PM
Feb 18, 2025 09:00AM
Jan 16, 2025 04:07PM
Dec 11, 2024 09:44AM
Dec 2, 2024 04:14PM JPMorgan Reiterates Overweight Rating on PTC Therapeutics (PTCT)
Nov 5, 2024 07:05AM
Oct 28, 2024 04:44PM
Oct 26, 2024 07:50PM
Sep 24, 2024 08:45AM
Sep 20, 2024 09:00AM
Sep 17, 2024 01:00PM
Aug 28, 2024 07:09AM Novartis (NVS) twice-yearly Leqvio demonstrated clinically meaningful, statistically significant LDL-C lowering as a monotherapy in patients at low or moderate ASCVD risk
Aug 7, 2024 02:23PM
Aug 6, 2024 09:00AM
Jul 30, 2024 07:00AM
May 25, 2024 06:00AM
May 7, 2024 07:00AM
Apr 30, 2024 10:14AM
Apr 23, 2024 01:58PM Novartis (NVS) Announces FDA Approval of Lutathera
Apr 17, 2024 01:20AM
Apr 15, 2024 02:02PM
Feb 27, 2024 08:05AM
Feb 27, 2024 08:00AM
Feb 25, 2024 02:00PM
Feb 16, 2024 11:20AM
Feb 14, 2024 08:01AM Erasca (ERAS) Announces Two Clinical Trial Collaboration and Supply Agreements for Trametinib to Evaluate Naporafenib Combination in SEACRAFT-1 and SEACRAFT-2 Trials
Feb 14, 2024 08:00AM
Feb 5, 2024 05:17PM
Feb 5, 2024 04:49PM
Feb 5, 2024 11:47AM
Jan 5, 2024 09:24AM
Jan 5, 2024 09:23AM
Dec 11, 2023 03:45AM Novartis (NVS) Presents new 48-week Results from Phase III APPLY-PNH Study
Dec 10, 2023 07:39PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All